Exploring the role of psychosocial care in value-based oncology: Results from a survey of 3000 cancer patients and survivors.


Journal

Journal of psychosocial oncology
ISSN: 1540-7586
Titre abrégé: J Psychosoc Oncol
Pays: United States
ID NLM: 8309337

Informations de publication

Date de publication:
Historique:
pubmed: 20 11 2018
medline: 7 3 2020
entrez: 20 11 2018
Statut: ppublish

Résumé

To explore the psychosocial needs of cancer patients and survivors across the United States and their implications for value-based oncology. A secondary analysis of findings from a cross-sectional national online survey. Respondents were sampled and stratified by cancer type and geographic region to approximate the cancer-affected population of the United States. Breast, prostate, and colorectal were the most common cancers reported. Across surveys, the majority of respondents were female (57%), over 55 (60%), and white (70%) and had at least some college (36%). Six online surveys were administered to cohorts of approximately 500 unique cancer patients and survivors. Survey topics included: (1) diagnosis, (2) treatment planning, (3) communication with providers, (4) insurance and financial concerns, (5) quality of life, side effects, and symptoms, and (6) survivorship and end-of-life. Descriptive analyses were used to explore psychosocial needs and experiences across three domains of patient-centered value in oncology. Each survey received 500-527 responses. Respondents most commonly reported needing more information regarding their insurance coverage and out-of-pocket costs (65%), access to clinical trials (89%), and support organizations (45%). Forty-one percent were very or extremely distressed about cancer's impact on their ability to work and over 25% reported high-levels of cancer-related financial hardship. Patients and survivors reported significant unmet informational needs, financial hardship, distress, and symptoms or treatment side effects that interfered with daily life. Implications for Psychosocial Providers or Policy: Providers and payment reform advocates can improve value in oncology by ensuring access to comprehensive psychosocial care and informational support.

Identifiants

pubmed: 30451102
doi: 10.1080/07347332.2018.1504851
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

441-455

Auteurs

Meredith Doherty (M)

a Graduate Center of the City University of New York , New York , NY , USA.

Ellen Miller-Sonet (E)

b CancerCare , New York , NY , USA.

Daniel Gardner (D)

c Silberman School of Social Work at Hunter College , City University of New York , New York , NY , USA.

Irwin Epstein (I)

c Silberman School of Social Work at Hunter College , City University of New York , New York , NY , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH